Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04736940Unknown

Definition of Crises in Medical Oncology: a Two-way Perspective of Patients and Caregivers. The COPE Study. (COPE)

Role: collaborator

NCT02025062Not ApplicableCompleted

Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients

Role: collaborator

NCT02884375Recruiting

Elderly CAncer Patient

Role: collaborator

NCT00948883Completed

Study of Cancers After Solid Organs Transplants

Role: collaborator

All 4 trials loaded